相关实验视频
Updated: May 21, 2025

05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
2.7K
复发性/耐药性神经母细胞瘤的机制和分子特征
Chong Chen1, Zixuan Wei2,3,4,5
1Department of Clinical Laboratory, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
Frontiers in oncology
|March 21, 2025
概括
儿童复发性/耐药性神经母细胞瘤的预后不佳,原因是 MYCN 放大等复杂的分子变化. 了解这些机制是开发有针对性的精密治疗的关键.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 复发性/耐药性神经母细胞瘤是一种高风险的儿科癌症,治疗选择有限.
- 这种疾病的复杂性涉及多种遗传变化和分子途径.
- 确定关键的分子驱动因素对于改善患者的治疗结果至关重要.
研究的目的:
- 审查复发性/耐药性神经母细胞瘤的分子机制和特征.
- 探索这些分子特征,治疗反应和预后之间的联系.
- 为开发新的个性化疗法提供基础.
主要方法:
- 关于神经母细胞瘤病变的最新研究的文献综述.
- 分析关键的分子变异,包括MYCN放大,ALK突变和TERT促进子突变.
- 综合关于p53通路失活和染色体不稳定性的信息.
主要成果:
- MYCN放大,ALK突变,TERT促进子突变,p53通路无活化和染色体不稳定被确定为关键机制.
- 这些分子特征与治疗耐药性和不良预后有关.
- 针对这些特定的变化在临床前和临床环境中显示出有希望的结果.
结论:
- 了解复发性/耐药性神经母细胞瘤的分子格局对于推进治疗策略至关重要.
- 精准医学方法针对已识别的分子驱动因素,为改善结果提供了希望.
- 需要进一步的研究来开发和优化针对受影响儿童的个性化治疗方案.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.2K
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K